0001104659-25-107873
SEC filingDDS revenue surged 73.9% to $156.2M; $30M revolver undrawn; cash $73.9M; no purchase commitments disclosed.
Cash and cash equivalents totaled $73.9M as of September 30, 2025, up from $46.9M at year-end 2024, driven by strong operating cash flow. The company maintains a $30.0M undrawn revolving credit facility (Wells Fargo) with a fixed charge coverage ratio covenant of 1.10x. Total debt (pension obligations and Microsoft licenses) stood at $8.8M, consisting primarily of pension liabilities ($8.7M) and current portion of $1.2M. The current ratio improved to 2.7x (current assets $119.8M vs. current liabilities $44.5M).
No material purchase commitments or contractual obligations were disclosed in the Notes, aside from operating lease obligations of $5.6M (undiscounted) and the Microsoft license agreement requiring $0.4M annually through February 2026. A contingent liability related to a Philippine labor judgment ($5.6M + interest) remains unresolved, with a preliminary injunction in place.
No share repurchases or dividends were executed during the period. The company did not draw on its credit facility. Capital expenditures ($8.3M per cash flow statement) were primarily for software development and IT infrastructure, but not detailed in the Notes.
The Digital Data Solutions (DDS) segment is the primary growth driver, generating 87% of total revenue in the nine-month period. DDS revenue grew 73.9% YoY to $156.2M, with operating margin of 18.6%. Synodex revenue declined slightly to $5.7M but remained profitable. Agility posted a small operating loss as it scaled subscription revenue. Geographically, the U.S. contributed 84% of total revenue, with Canada, UK, and Netherlands as the next largest markets. Customer concentration is high: one DDS customer accounted for 58% of total revenue in the nine-month period and 56% in Q3 2025.
Net income of $23.3M translated into operating cash flow of $33.9M, a cash conversion ratio of 1.45x, indicating strong cash generation. Key non-cash adjustments included stock-based compensation ($8.3M), depreciation and amortization ($4.9M), and deferred income taxes ($3.2M). Working capital changes consumed cash primarily due to an $11.2M increase in accounts receivable, partially offset by a $6.9M rise in accounts payable. The company invested $8.3M in capital expenditures, up from $5.5M in the prior year, reflecting growth initiatives. Financing activities provided $1.1M, mainly from stock option exercises ($1.5M) net of withholding taxes and debt payments. Overall, strong operating cash flow funded capex and modest financing needs, with cash balance increasing to $73.9M from $46.9M at the start of the period.